Register entry
ANACOR PHARMACEUTICALS INC
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 8
- Countries
- 0
Exclusivity
Patents and exclusivities
8| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8501712 | EUCRISAcrisaborole | use | Feb 2027 |
| 9682092 | EUCRISAcrisaborole | use | Feb 2027 |
| 8501712*PED | EUCRISAcrisaborole | use | Aug 2027 |
| 9682092*PED | EUCRISAcrisaborole | use | Aug 2027 |
| 8039451 | EUCRISAcrisaborole | substance, product | Jun 2029 |
| 8039451*PED | EUCRISAcrisaborole | use | Dec 2029 |
| 8168614 | EUCRISAcrisaborole | use | Jan 2030 |
| 8168614*PED | EUCRISAcrisaborole | use | Jul 2030 |
Enquiry
Common questions
- Is ANACOR PHARMACEUTICALS INC FDA approved?
- ANACOR PHARMACEUTICALS INC holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.